|

Copper Cu 64 Anti-CEA Monoclonal Antibody M5A Clinical Trials

1 actively recruiting trial across 1 location

Also known as: 64Cu-DOTA-M5A, Cu 64-M5A

Pipeline

Early 1: 1

Top Sponsors

  • City of Hope Medical Center1

Indications

  • Stage IIIC Rectal Cancer AJCC v81
  • Stage IIIB Rectal Cancer AJCC v81
  • Stage IIIA Rectal Cancer AJCC v81
  • Stage III Rectal Cancer AJCC v81
  • Locally Advanced Rectal Carcinoma1

Duarte, California1 trial

An Investigational Scan (64Cu-Labeled M5A Antibody) in Combination With SOC Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer

City of Hope Medical Center

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.